Tag: clinical tests

Newer, Smaller Analyzers Will Bring Big Data to Labs

Cepheid-GeneXpert-System

CEO SUMMARY: Clinical laboratories of all sizes are poised to become the source of much of a hospital or health system’s “big data.” At many academic center labs, greater use of genetic and molecular testing requires that more space and more staff be devoted to data management. At the same time, the latest generation of gene sequencing instruments and molecular analyzers are cheaper, faster, and more automated. These systems make it feasible for even smaller labs to offer sophisticated genetic tests.

View Article

FL Docs Say: ‘No Thanks’ to UHC and BeaconLBS

CEO SUMMARY: Some Florida physicians are declaring their intent to leave UnitedHealthcare’s network because they find the insurer’s new BeaconLBS laboratory benefit management system to be time consuming and onerous. The defections come as the program goes through a soft launch that began on October 1. Apparently in response to physician complaints, UHC announced a

View Article

Exome Sequencing Next “Big Thing” for Diagnosis

CEO SUMMARY: For disease diagnostics, exome sequencing is not yet routine, but geneticists are getting close. Using this technology, researchers read those parts of the human genome where about 85% of disease-causing mutations reside. By looking only at the regions that encode proteins—the workhorse machinery of the cell—researchers identify dis- ease causes much faster than

View Article

Pennsylvania Lab Earns ISO 15189 Accreditation

CEO SUMMARY: Clinical laboratories often promote themselves as being able to deliver quality results. But simply saying so is not the same as having an outside organization audit the laboratory to accredit its analytical processes and its other operational activities. NMS Labs in Willow Grove, Pennsylvania, pursued accreditation to ISO 15189 Medical Laboratories to gain

View Article

Hospital Labs Have New Options for Molecular Dx

CEO SUMMARY: Laboratories that offer molecular assays continue to see strong growth in four areas: oncology, hematopathology, infectious diseases, and personalized medicine. Further, a new generation of molecular testing systems and analyzers is coming to market which will make it easier for even smaller community hospital laboratories to establish and perform molecular tests that are

View Article

Laboratories Sit Squarely Between New Genetics and Today’s Medicine

“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson.

CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary changes in the American healthcare system. In particular, Carlson predicts consumers will drive the primary shift in the way healthcare services are

View Article